Denali Therapeutics Inc Share | Buy US Stock from India on Kuvera

Q: Can I buy Denali Therapeutics Inc shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Denali Therapeutics Inc stocks after a simple registration process. </div>

Q: How to buy Denali Therapeutics Inc shares in India?

<div> To buy Denali Therapeutics Inc shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Denali Therapeutics Inc and you are done!</div> </div>

Q: What is the share price of Denali Therapeutics Inc?

<div>The share price of Denali Therapeutics Inc is USD 16.81 as on 2 May.</div>

Q: What is the Market Capitalization of Denali Therapeutics Inc?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Denali Therapeutics Inc is USD 2.4B as on 2 May.</div>

Q: What is the PE ratio of Denali Therapeutics Inc?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Denali Therapeutics Inc is -15.86 as on 2 May. </div>

Q: Is Denali Therapeutics Inc a good stock to buy?

<div>Kuvera provides relevant fundamental details of Denali Therapeutics Inc to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Denali Therapeutics Inc operate?

<div> Denali Therapeutics Inc operates in Healthcare / Biotechnology

Healthcare Biotechnology

$16.81

+0.65

(2 May)

Loading Chart

Previous close

$16.81

Open

$16.81

Today’s high

$16.94

Today’s low

$15.92

52W low

$14.56

52W high

$33.31

-30.98%

-7.04%

-15.86

EPS (TTM)

-1.06

Shares O/S

142.54M

Market cap

2.4B

Insights

DNLI price is above its 200 day moving average

DNLI PE is in the low end of its range over the past 2 years

DNLI is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Denali Therapeutics Inc

Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates.

Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome). .

FAQs

Can I buy Denali Therapeutics Inc shares in India?

How to buy Denali Therapeutics Inc shares in India?

What is the share price of Denali Therapeutics Inc?

What is the Market Capitalization of Denali Therapeutics Inc?

What is the PE ratio of Denali Therapeutics Inc?

Is Denali Therapeutics Inc a good stock to buy?

In which sector / industry does Denali Therapeutics Inc operate?